MoneyWorks4Me

The sales slipped to Rs. 17300.00 millions for the June 2023 quarter as against Rs. 22040.00 millions during the year-ago period.The Company to register a -50.07%  fall in the net profit for the quarter ended June 2023.A decline of 5710.00 millions was observed in the OP in the quarter ended June 2023 from 9270.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 17300.00 22040.00 -21.51 17300.00 22040.00 -21.51 76253.00 88798.20 -14.13
Other Income 800.00 900.00 -11.11 800.00 900.00 -11.11 3490.10 1112.60 213.69
PBIDT 5710.00 9270.00 -38.40 5710.00 9270.00 -38.40 26966.90 39877.20 -32.38
Interest 0.00 0.00 0.00 0.00 0.00 0.00 5.20 6.50 -20.00
PBDT 5710.00 9270.00 -38.40 5710.00 9270.00 -38.40 26961.70 39870.70 -32.38
Depreciation 930.00 830.00 12.05 930.00 830.00 12.05 3420.70 3105.50 10.15
PBT 4780.00 8440.00 -43.36 4780.00 8440.00 -43.36 23541.00 36765.20 -35.97
TAX 1330.00 1530.00 -13.07 1330.00 1530.00 -13.07 5459.50 7279.80 -25.00
Deferred Tax 100.00 150.00 -33.33 100.00 150.00 -33.33 1083.70 907.80 19.38
PAT 3450.00 6910.00 -50.07 3450.00 6910.00 -50.07 18081.50 29485.40 -38.68
Equity 530.00 530.90 -0.17 530.00 530.90 -0.17 530.90 530.90 0.00
PBIDTM(%) 33.01 42.06 -21.53 33.01 42.06 -21.53 35.37 44.91 -21.25
Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..